Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01926938 · ClinicalTrials.gov registry record

Endothelial Function in Young Hispanic Adults at Risk for Type 2 Diabetes

A clinical trial, sponsored by Joslin Diabetes Center.

Completed
Registry status
44
Enrollment target

NCT01926938 is a clinical trial that has completed, run by Joslin Diabetes Center. The registered enrollment target is 44 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01926938 has completed, sponsored by Joslin Diabetes Center.

COMPLETED
Registry status
44 participants
Enrollment target

Study Summary

Diabetes is a major public health problem. Hispanics/Latinos are known to be at higher risk for type 2 diabetes. The function of the endothelium has played a key role in the understanding of vascular complications in people with diabetes. Endothelial function and vascular reactivity are impaired not only in white adults with type 2 diabetes but also in those at risk for the disease by virtue of having impaired glucose tolerance or parental history of type 2 diabetes. Whether this finding is applicable to hispanics is not known. The investigators plan to assess the endothelial function and vascular reactivity in young Hispanic adults at risk of developing type 2 diabetes by virtue of being obese and belonging to a minority population.

Trial Details

FieldValue
Enrollment Target 44 participants
Start Date 2003-05
Est. Completion 2013-01

Sponsor

Joslin Diabetes Center

73 total trials

What the Registry Record Tells You About NCT01926938

The ClinicalTrials.gov registry entry for NCT01926938 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 44 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Joslin Diabetes Center, which has 73 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01926938 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01926938 about?

NCT01926938 is a clinical study titled "Endothelial Function in Young Hispanic Adults at Risk for Type 2 Diabetes". Diabetes is a major public health problem. Hispanics/Latinos are known to be at higher risk for type 2 diabetes. The function of the endothelium has played a key role in the understanding of vascular complications in people with diabetes. Endothelial function and vascular reactivity are impaired not...

What is the current status of trial NCT01926938?

This trial is currently completed. The enrollment target is 44 participants. The study started on 2003-05. Estimated completion is 2013-01.

Who is sponsoring clinical trial NCT01926938?

This trial is sponsored by Joslin Diabetes Center, which has 73 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.